• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质组学分析鉴定翻译控制肿瘤蛋白为肝再生磷酸酶-3 促进人结肠癌细胞增殖、迁移和侵袭的介质。

Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.

机构信息

Department of Gastroenteropancreatic Surgery, the Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China.

出版信息

Chin Med J (Engl). 2011 Nov;124(22):3778-85.

PMID:22340241
Abstract

BACKGROUND

Considerable evidence suggests that phosphatase of regenerating liver-3 (PRL-3) plays multiple roles in cancer metastasis; however, the molecular mechanisms remain largely unknown. The aim of this study was to identify proteins associated with PRL-3-promoted colon cancer metastasis, by comparative proteomic analysis.

METHODS

Proteomes of human colon cancer LoVo cells transfected with PRL-3 gene (LoVo-PRL-3) or empty vector PAcGFP-C3 (LoVo-control) were compared using 2D gel electrophoresis. Proteins that varied significantly in concentration were selected and identified using mass spectrometry. Expression of translationally controlled tumor protein (TCTP) mRNA and protein in LoVo-PRL-3 and LoVo-control cells was detected by real-time PCR and Western blotting. Small interfering RNA (siRNA) targeting TCTP was used for silencing TCTP expression in LoVo-PRL-3 cells. Functional significance of TCTP in PRL-3-promoted colon cancer cell proliferation, migration and invasion was investigated by Cell Counting Kit-8 assay and transwell chamber.

RESULTS

Seventeen proteins displaying significant and reproducible differences between LoVo-PRL-3 and LoVo-control cells were identified. Ten proteins were upregulated and seven were downregulated in LoVo-PRL-3 cells when compared with LoVo-control cells. Eight identified proteins are associated with distinct steps of tumor metastasis: ubiquitin-like protein ISG15, interleukin-18, TCTP, serpin B5, annexin A3, macrophage-capping protein, ATP-dependent RNA helicase DDX3X, and cathepsin D. Real-time PCR and Western blotting results showed that both TCTP mRNA and protein were significantly increased in LoVo-PRL-3 cells compared to LoVo-control cells. Transfection with TCTP siRNA significantly reduced the expression of both mRNA and protein levels of TCTP in LoVo-PRL-3 cells. Knockdown of TCTP by siRNA inhibited PRL-3-promoted proliferation, migration and invasion of LoVo-PRL-3 cells.

CONCLUSION

Our results imply that TCTP might be a mediator of PRL-3-promoted proliferation, migration and invasion of human colon cancer cells.

摘要

背景

大量证据表明,肝再生磷酸酶-3(PRL-3)在癌症转移中发挥多种作用;然而,其分子机制在很大程度上仍然未知。本研究旨在通过比较蛋白质组学分析,鉴定与 PRL-3 促进结肠癌转移相关的蛋白质。

方法

使用二维凝胶电泳比较转染 PRL-3 基因(LoVo-PRL-3)或空载体 PAcGFP-C3(LoVo-control)的人结肠癌 LoVo 细胞的蛋白质组。选择浓度差异显著的蛋白质,并使用质谱法进行鉴定。通过实时 PCR 和 Western blot 检测 LoVo-PRL-3 和 LoVo-control 细胞中转译控制肿瘤蛋白(TCTP)mRNA 和蛋白的表达。用靶向 TCTP 的小干扰 RNA(siRNA)沉默 LoVo-PRL-3 细胞中的 TCTP 表达。通过细胞计数试剂盒-8 测定和 Transwell 室实验研究 TCTP 在 PRL-3 促进结肠癌细胞增殖、迁移和侵袭中的功能意义。

结果

在 LoVo-PRL-3 和 LoVo-control 细胞之间鉴定出 17 种显示出显著且可重复差异的蛋白质。与 LoVo-control 细胞相比,LoVo-PRL-3 细胞中有 10 种蛋白质上调,7 种蛋白质下调。鉴定出的 8 种蛋白质与肿瘤转移的不同步骤有关:泛素样蛋白 ISG15、白细胞介素-18、TCTP、丝氨酸蛋白酶抑制剂 B5、膜联蛋白 A3、巨噬细胞封顶蛋白、ATP 依赖的 RNA 解旋酶 DDX3X 和组织蛋白酶 D。实时 PCR 和 Western blot 结果显示,与 LoVo-control 细胞相比,LoVo-PRL-3 细胞中的 TCTP mRNA 和蛋白表达均显著增加。用 TCTP siRNA 转染显著降低了 LoVo-PRL-3 细胞中 TCTP 的 mRNA 和蛋白水平的表达。用 siRNA 敲低 TCTP 抑制了 PRL-3 促进的 LoVo-PRL-3 细胞的增殖、迁移和侵袭。

结论

我们的结果表明,TCTP 可能是 PRL-3 促进人结肠癌细胞增殖、迁移和侵袭的介质。

相似文献

1
Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.蛋白质组学分析鉴定翻译控制肿瘤蛋白为肝再生磷酸酶-3 促进人结肠癌细胞增殖、迁移和侵袭的介质。
Chin Med J (Engl). 2011 Nov;124(22):3778-85.
2
The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells.翻译控制肿瘤蛋白在结肠腺癌细胞肿瘤生长和转移中的作用。
J Proteome Res. 2010 Jan;9(1):40-9. doi: 10.1021/pr9001367.
3
PRL-3 promotes the proliferation of LoVo cells via the upregulation of KCNN4 channels.PRL-3 通过上调 KCNN4 通道促进 LoVo 细胞的增殖。
Oncol Rep. 2011 Oct;26(4):909-17. doi: 10.3892/or.2011.1366. Epub 2011 Jun 28.
4
Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.Stathmin,一种通过蛋白质组学方法鉴定的 PRL-3 的新靶点,在结直肠癌的进展和转移中发挥关键作用。
J Proteome Res. 2010 Oct 1;9(10):4897-905. doi: 10.1021/pr100712t.
5
PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.PRL-3 通过 PRL-3-整合素 β1-ERK1/2 和-MMP2 信号促进 LoVo 结肠癌细胞的迁移、侵袭和转移。
Mol Cancer. 2009 Nov 24;8:110. doi: 10.1186/1476-4598-8-110.
6
Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.肝再生磷酸酶-3 通过上调基质金属蛋白酶-7 促进人结直肠癌细胞的迁移和侵袭。
Int J Cancer. 2012 Aug 1;131(3):E190-203. doi: 10.1002/ijc.27381. Epub 2012 Jan 11.
7
Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.PRL-3 的组成性抑制可抑制胃癌细胞在体外和体内的侵袭和增殖。
Pathobiology. 2010;77(3):155-62. doi: 10.1159/000292649. Epub 2010 May 28.
8
[Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].[再生肝脏磷酸酶-3在胃癌中的表达、其与预后的关系及其在胃癌细胞增殖中的作用]
Zhonghua Yi Xue Za Zhi. 2008 Aug 26;88(33):2326-30.
9
Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.升高的肝再生磷酸酶 3(PRL-3)促进了内异症子宫内膜基质细胞中细胞骨架的重排、细胞迁移和侵袭。
Hum Reprod. 2016 Apr;31(4):723-33. doi: 10.1093/humrep/dew015. Epub 2016 Feb 13.
10
Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.翻译控制肿瘤蛋白通过高迁移率族蛋白 1 依赖性途径影响结直肠癌转移。
Int J Oncol. 2018 Oct;53(4):1481-1492. doi: 10.3892/ijo.2018.4502. Epub 2018 Jul 25.

引用本文的文献

1
The multifaceted potential of as biomarker and therapeutic target.作为生物标志物和治疗靶点的多方面潜力。 (你提供的原文有缺失内容,推测原句可能是The multifaceted potential of [某个事物] as biomarker and therapeutic target )
Heliyon. 2024 Oct 1;10(19):e38819. doi: 10.1016/j.heliyon.2024.e38819. eCollection 2024 Oct 15.
2
Biological role and expression of translationally controlled tumor protein (TCTP) in tumorigenesis and development and its potential for targeted tumor therapy.翻译控制肿瘤蛋白(TCTP)在肿瘤发生发展中的生物学作用、表达及其在肿瘤靶向治疗中的潜力。
Cancer Cell Int. 2024 Jun 4;24(1):198. doi: 10.1186/s12935-024-03355-9.
3
Translationally controlled tumor protein: the mediator promoting cancer invasion and migration and its potential clinical prospects.
翻译控制肿瘤蛋白:促进癌症侵袭和转移的介质及其潜在的临床前景。
J Zhejiang Univ Sci B. 2022 Aug 15;23(8):642-654. doi: 10.1631/jzus.B2100910.
4
HpSlyD inducing CDX2 and VIL1 expression mediated through TCTP protein may contribute to intestinal metaplasia in the stomach.HpSlyD 通过 TCTP 蛋白诱导 CDX2 和 VIL1 表达可能有助于胃的肠上皮化生。
Sci Rep. 2017 May 23;7(1):2278. doi: 10.1038/s41598-017-02642-y.
5
Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.翻译调控肿瘤蛋白TCTP在人类结直肠癌肿瘤早期被诱导,并导致HCT116结肠癌细胞对5-氟尿嘧啶和奥沙利铂产生耐药性。
Cell Commun Signal. 2017 Feb 1;15(1):9. doi: 10.1186/s12964-017-0164-3.
6
RNA interference‑mediated knockdown of translationally controlled tumor protein induces apoptosis, and inhibits growth and invasion in glioma cells.RNA干扰介导的翻译控制肿瘤蛋白敲低可诱导胶质瘤细胞凋亡,并抑制其生长和侵袭。
Mol Med Rep. 2015 Nov;12(5):6617-25. doi: 10.3892/mmr.2015.4280. Epub 2015 Sep 2.
7
Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.结直肠癌干细胞和化疗耐药性结直肠癌细胞表型以及对Notch信号通路抑制剂敏感性增加。
Mol Med Rep. 2015 Aug;12(2):2417-24. doi: 10.3892/mmr.2015.3694. Epub 2015 Apr 28.